Civic Intelligence

Strobis Glaucoma Foundation Inc

990EZ • Fiscal year 2012 • EIN 03-0439852

Jan 01, 2012 to Dec 31, 2012

Boca Raton, FL
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

53rd percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2012 filings • 501(c)3 • <$500k nonprofits • Source year 2012

Liabilities / Revenue

57th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2012 filings • 501(c)3 • <$500k nonprofits • Source year 2012

Net Margin

4th percentile

-112%

Higher net margin than 4% of similar nonprofits.

2012 filings • 501(c)3 • <$500k nonprofits • Source year 2012

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2012

Asset Growth

10th percentile

-46%

Faster asset growth than 10% of similar nonprofits.

2012 filings • 501(c)3 • <$500k nonprofits • Annualized from 2011 to 2012

Revenue Growth

11th percentile

-44%

Faster revenue growth than 11% of similar nonprofits.

2012 filings • 501(c)3 • <$500k nonprofits • Annualized from 2011 to 2012

Assets

Down

$61,941

Down $53,821 (-46%) from 2011

Net Assets

-

No earlier filing loaded for comparison.

Liabilities

Flat

$0

Flat from 2011

Revenue

Down

$48,215

Down $38,110 (-44%) from 2011

Expenses

Up

$102,036

Up $1,022 (+1.0%) from 2011

Net Income

Down

-$53,821

Down $39,132 (-266%) from 2011

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$400K$300K$200K$100K$0Assets 2010: $130,451Liabilities 2010: $02010Assets 2011: $115,762Liabilities 2011: $02011Assets 2012: $61,941Liabilities 2012: $02012Assets 2013: $302,055Liabilities 2013: $0Net Assets 2013: $302,0552013Assets 2014: $226,792Liabilities 2014: $0Net Assets 2014: $226,7922014Assets 2015: $162,948Liabilities 2015: $0Net Assets 2015: $162,9482015Assets 2016: $129,182Liabilities 2016: $0Net Assets 2016: $129,1822016Assets 2017: $68,336Liabilities 2017: $0Net Assets 2017: $68,3362017Assets 2018: $149,951Liabilities 2018: $61Net Assets 2018: $149,8902018Assets 2019: $223,946Liabilities 2019: $0Net Assets 2019: $223,9462019Assets 2020: $142,584Liabilities 2020: $0Net Assets 2020: $142,5842020Assets 2021: $71,839Liabilities 2021: $0Net Assets 2021: $71,8392021Assets 2022: $121,023Liabilities 2022: $0Net Assets 2022: $121,0232022

Highlighted filing

2012

Assets$61,941
Liabilities$0
Net Assets-

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500KRevenue 2010: $84,345Expenses 2010: $110,894Net Income 2010: -$26,5492010Revenue 2011: $86,325Expenses 2011: $101,014Net Income 2011: -$14,6892011Revenue 2012: $48,215Expenses 2012: $102,036Net Income 2012: -$53,8212012Revenue 2013: $744,900Expenses 2013: $504,786Net Income 2013: $240,1142013Revenue 2014: $48,956Expenses 2014: $124,219Net Income 2014: -$75,2632014Revenue 2015: $51,850Expenses 2015: $115,694Net Income 2015: -$63,8442015Revenue 2016: $68,125Expenses 2016: $101,891Net Income 2016: -$33,7662016Revenue 2017: $40,990Expenses 2017: $101,836Net Income 2017: -$60,8462017Revenue 2018: $190,400Expenses 2018: $108,846Net Income 2018: $81,5542018Revenue 2019: $189,905Expenses 2019: $115,849Net Income 2019: $74,0562019Revenue 2020: $25,025Expenses 2020: $106,387Net Income 2020: -$81,3622020Revenue 2021: $34,950Expenses 2021: $105,695Net Income 2021: -$70,7452021Revenue 2022: $50,029Expenses 2022: $845Net Income 2022: $49,1842022

Highlighted filing

2012

Revenue$48,215
Expenses$102,036
Net Income-$53,821
Filing Detail Status

This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2012 to Dec 31, 2012
Mission and Program Overview

Mission

The organization's primary exempt purpose is to solicit contributions for the study of glaucoma and other eye diseases.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings